Learn More
Medchemexpress LLC Bhpi | 56632-39-4 | 98.0% | 10 MG

Supplier: Medchemexpress LLC HY1282510MG
BHPI is a nuclear receptor ERα inhibitor that activates PLCγ and UPR. It exhibits potent antitumor activity against various cancers, including breast, endometrial, and ovarian cancers.
- Inhibits proliferation of ERα-positive breast, endometrial, and ovarian cancer cells.
- Inhibits cell proliferation in two-dimensional adherent cultures of T47D, ERαY537S-4, and ERαD538G-1 cells.
- Demonstrates in vivo tumor growth inhibition and regression in mouse xenograft models using MCF-7 tumors.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.